Cargando…

Effects of Glycyrrhizic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARγ), Lipoprotein Lipase (LPL), Serum Lipid and HOMA-IR in Rats

Studies on ligand binding potential of glycyrrhizic acid, a potential agonist to PPARγ, displayed encouraging results in amelioration of metabolic syndrome. The regulation of gene cassettes by PPARγ affects glucose homeostasis, lipid, lipoprotein metabolism and adipogenesis. This study was performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoke Yin, Chia, So Ha, Ton, Abdul Kadir, Khalid
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786009/ https://www.ncbi.nlm.nih.gov/pubmed/20011054 http://dx.doi.org/10.1155/2010/530265

Ejemplares similares

Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats
por: Lim, Wai Yen Alfred, et al.
Publicado: (2009)

Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats
por: Eu, Chia Hui Apphia, et al.
Publicado: (2010)

Rare novel LPL mutations are associated with neonatal onset lipoprotein lipase (LPL) deficiency in two cases
por: Wu, Yun Qin, et al.
Publicado: (2021)

The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism
por: Wieczorek, Ewa, et al.
Publicado: (2021)

Lipoprotein Lipase (LPL) Polymorphism and the Risk of Coronary Artery Disease: A Meta-Analysis
por: Xie, Li, et al.
Publicado: (2017)

Variability in HOMA-IR, Lipoprotein Profile and Selected Hormones in Young Active Men
por: Keska, Anna, et al.
Publicado: (2013)

Homozygous LPL p.Gly188Glu Mutation in a Mexican Girl With Lipoprotein Lipase Deficiency
por: Colima Fausto, Ana Gabriela, et al.
Publicado: (2017)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) in vitro
por: Alexander, Stephen PH, et al.
Publicado: (2012)

Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders
por: Ren, Ping, et al.
Publicado: (2015)

Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?
por: Khalili, Davood, et al.
Publicado: (2023)

Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
por: Lemaitre, Rozenn N., et al.
Publicado: (2018)

Lipoprotein Lipase (LPL) is Associated with Neurite Pathology and Its Levels Are Markedly Reduced in the Dentate Gyrus of Alzheimer’s Disease Brains
por: Gong, Huilin, et al.
Publicado: (2013)

Prevalence of insulin resistance and identifying HOMA1-IR and HOMA2-IR indexes in the Middle Black Sea region of Turkey
por: Demir, Ayşe Kevser, et al.
Publicado: (2020)

Triflumizole Is an Obesogen in Mice that Acts through Peroxisome Proliferator Activated Receptor Gamma (PPARγ)
por: Li, Xia, et al.
Publicado: (2012)

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
por: Wang, Limei, et al.
Publicado: (2014)

Peroxisome proliferator‐activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut
por: Fumery, Mathurin, et al.
Publicado: (2017)

The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III Hyperlipidemia
por: Evans, David, et al.
Publicado: (2007)

The HindIII and PvuII polymorphisms of lipoprotein lipase (LPL) gene reduce the risk of ischemic stroke (IS): A meta-analysis
por: Cao, Limei, et al.
Publicado: (2018)

The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS)
por: Vilela, Brunna Sullara, et al.
Publicado: (2016)

High HOMA-IR Index in Healthcare Shift Workers
por: Ledda, Caterina, et al.
Publicado: (2019)

Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)
por: O'Sullivan, Saoirse E., et al.
Publicado: (2009)

Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?
por: Green, David E., et al.
Publicado: (2011)

The involvement of peroxisome proliferator-activated receptor gamma (PPARγ) in anti-inflammatory activity of N-stearoylethanolamine
por: Kosiakova, H., et al.
Publicado: (2022)

Gamma (γ) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (γ) expression in SW 480 human colon cancer cell lines
por: Campbell, Sharon E, et al.
Publicado: (2003)

PPARγ as a sensor of lipase activity and a target for the lipase inhibitor orlistat
por: Martin, Harry, et al.
Publicado: (2013)

Resequencing of LPL in African Blacks and associations with lipoprotein–lipid levels
por: Pirim, Dilek, et al.
Publicado: (2015)

Genotyping of peroxisome proliferator-activated receptor gamma (PPAR-γ) polymorphism (Pro12Ala) in Iranian population
por: Namvaran, Fatemeh, et al.
Publicado: (2011)

Birth-weight, insulin levels, and HOMA-IR in newborns at term
por: Simental-Mendía, Luis E, et al.
Publicado: (2012)

Expression Levels of GABA-A Receptor Subunit Alpha 3, Gabra3 and Lipoprotein Lipase, Lpl Are Associated with the Susceptibility to Acetaminophen-Induced Hepatotoxicity
por: Kim, Minjeong, et al.
Publicado: (2017)

Case Report: Next-Generation Sequencing Identified a Novel Pair of Compound-Heterozygous Mutations of LPL Gene Causing Lipoprotein Lipase Deficiency
por: Li, Yakun, et al.
Publicado: (2022)

Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours
por: Marques, A R, et al.
Publicado: (2004)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

Stress and Its Effects on Glucose Metabolism and 11β-HSD Activities in Rats Fed on a Combination of High-Fat and High-Sucrose Diet with Glycyrrhizic Acid
por: Fernando, Hamish Alexander, et al.
Publicado: (2013)

Associations of the HOMA2‐%B and HOMA2‐IR with progression to diabetes and glycaemic deterioration in young and middle‐aged Chinese
por: Fan, Baoqi, et al.
Publicado: (2022)

Novel Inhibitory Effects of Glycyrrhizic Acid on the Accumulation of Advanced Glycation End Product and Its Receptor Expression
por: Cheng, Hong Sheng, et al.
Publicado: (2014)

Regional distribution of body fat in relation to DNA methylation within the LPL, ADIPOQ and PPARγ promoters in subcutaneous adipose tissue
por: Drogan, D, et al.
Publicado: (2015)

Homeostasis Model Assessment of IR (HOMA-IR) and Metabolic Syndrome (MetS) in First Episode Psychosis
por: Garcia De Jalon, E., et al.
Publicado: (2022)

Transcription of Human Resistin Gene Involves an Interaction of Sp1 with Peroxisome Proliferator-Activating Receptor Gamma (PPARγ)
por: Singh, Anil K., et al.
Publicado: (2010)

Benzoxazinones as Human Peroxisome Proliferator Activated Receptor Gamma (PPARγ) Agonists: A Docking Study Using Glide
por: Das, N., et al.
Publicado: (2011)

Peroxisome proliferator-activated receptor gamma (PPARγ) activation: a potential treatment for ascites syndrome in broiler chickens
por: Rahimi, Mahin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vklpgkk7vg50hkksaepi72i7ng